市場調查報告書
商品編碼
1434618
過敏診斷市場:按類型、產品類型、測試、最終用戶分類 - 2024-2030 年全球預測Allergy Diagnostics Market by Type (Drug Allergen, Food Allergen, Inhaled Allergen), Product Type (Assay Kits, Consumables, Instruments), Test, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年過敏診斷市場規模為59.2億美元,2024年達64.9億美元,2030年預計將達118億美元,複合年成長率為10.35%。
全球過敏診斷市場
主要市場統計 | |
---|---|
基準年[2023] | 59.2億美元 |
預測年份 [2024] | 64.9億美元 |
預測年份 [2030] | 118億美元 |
複合年成長率(%) | 10.35% |
過敏診斷是由合格的專業人員進行的測試,以確定患者的身體是否對已知化學物質過敏。過敏診斷測試可估算您體內通常與過敏相關的抗體和蛋白質的數量。隨著異位性皮膚炎、蕁麻疹和過敏性結膜炎等過敏性疾病的增加,對準確過敏診斷的需求也預計會增加。人群中多種過敏性疾病的發生導致人們越來越偏好早期檢測和診斷過敏原,從而需要有效的診斷測試和系統。然而,對過敏性疾病的認知有限、診斷測試成本高昂以及訓練有素的專業人員有限可能會阻礙預測期內的市場開拓。此外,該公司開始專注於開發基於人工智慧和機器學習的新過敏診斷測試和套件的研究工作,創造市場發展機會。
區域洞察
歐洲因其發達的製藥工業和不斷成長的治療藥物需求而在過敏診斷市場中佔據重要地位。老年人口的增加和過敏性疾病的增加也促進了該地區的成長。在美洲,由於呼吸道過敏性疾病的高發病率、過敏診斷意識層級的提高以及試管內血液檢測的採用,預計該市場在未來幾年將成長。 FDA 一直在指導食品業、消費者和其他相關人員如何最好地評估和控制食品中過敏原的風險。生技藥品評估與研究中心 (CBER) 負責監管多種促進北美市場成長的過敏原產品。由於醫療基礎設施的快速改善、未滿足的臨床需求以及對微創診斷工具的需求,預計亞太地區將成為成長最快的區域市場。由於阿拉伯聯合大公國生產和出口過敏診斷所需的設備和耗材的主要零件,沙烏地阿拉伯預計將在過敏診斷市場中成長。
FPNV定位矩陣
FPNV定位矩陣對於評估過敏診斷市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對過敏診斷市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2-市場開拓:我們深入研究利潤豐厚的新興市場並分析其在成熟細分市場的滲透率。
3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1-過敏診斷市場的市場規模和預測是多少?
2-在過敏診斷市場的預測期內,有哪些產品、細分市場、應用和領域需要考慮投資?
3-過敏診斷市場的技術趨勢和法律規範是什麼?
4-過敏診斷市場主要供應商的市場佔有率為何?
5-進入過敏診斷市場的合適型態和策略手段是什麼?
[187 Pages Report] The Allergy Diagnostics Market size was estimated at USD 5.92 billion in 2023 and expected to reach USD 6.49 billion in 2024, at a CAGR 10.35% to reach USD 11.80 billion by 2030.
Global Allergy Diagnostics Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 5.92 billion |
Estimated Year [2024] | USD 6.49 billion |
Forecast Year [2030] | USD 11.80 billion |
CAGR (%) | 10.35% |
An allergy diagnosis is a test performed by a qualified specialist to determine if the patient's body is allergic to known chemicals. Allergy diagnostics tests estimate the number of typical antibodies or proteins in the body that are associated with allergies. Rising cases of allergic diseases such as atopic dermatitis, hives, and allergic conjunctivitis are expected to elevate the need for accurate allergy diagnosis. The incidence of multiple allergic diseases among the population expands the preference for early detection and diagnosis of the allergen, creating a requirement for effective diagnostic tests or systems. However, limited awareness about allergic diseases and high costs of diagnostic tests, and the limited availability of trained professionals can impede the market development over the forecast period. Furthermore, the emerging emphasis on research activities to develop new allergy diagnostic tests or kits based on AI and ML by companies is creating an opportunity for market development.
Regional Insights
Europe has a significant landscape in the allergy diagnostics market due to a developed pharmaceutical industry and increasing demand for therapeutics. The growing geriatric population and rising incidences of allergic conditions also contribute to the region's growth. The market is expected to grow in the Americas in coming years owing to the high incidence of respiratory allergic disorders, rising awareness levels about allergy diagnostics, and the adoption of in vitro blood tests. The FDA has guided the food industry, consumers, and other stakeholders on the best ways to assess and manage allergen hazards in food. The Center for Biologics Evaluation and Research (CBER) regulates several allergenic products that contributed to market growth in North America. Asia-Pacific is expected to be the fastest-growing regional market due to rapidly improving healthcare infrastructure, unmet clinical needs, and demand for minimally invasive diagnostic tools. Saudi Arabia has a growing landscape in the allergy diagnostics market, as the UAE manufactures and exports major parts of instruments and consumables required for allergy diagnostics.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Allergy Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergy Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Allergy Diagnostics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello A/S, Allergy Therapeutics PLC, Astra Biotech GmbH, Bausch & Lomb Incorporated, Biomerieux SA, Danaher Corporation, Dr. Fooke-Achterrath Laboratorien GmbH, DST Diagnostische Systeme & Technologien GmbH, Erba Group, Eurofins Scientific, EUROIMMUN Medizinische Labordiagnostika AG, HAL Allergy B.V., Hitachi, Ltd., HOB Biotech Group Corp., Ltd., HollisterStier by Jubilant Life Sciences Limited, HYCOR Biomedical, Lincoln Diagnostics, Inc., Minaris Medical America, Inc., Neogen Corporation, Omega Diagnostics Group PLC, Parkway Pantai Ltd., R-Biopharm AG, Romer Labs Division Holding GmbH by Royal DSM, ROXALL Medizin GmbH, Siemens AG, Stallergenes Greer International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Allergy Diagnostics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergy Diagnostics Market?
3. What are the technology trends and regulatory frameworks in the Allergy Diagnostics Market?
4. What is the market share of the leading vendors in the Allergy Diagnostics Market?
5. Which modes and strategic moves are suitable for entering the Allergy Diagnostics Market?